Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.570
-0.020 (-0.77%)
May 20, 2024, 2:55 PM EDT - Market open
Armata Pharmaceuticals Revenue
Armata Pharmaceuticals had revenue of $4.70M in the twelve months ending March 31, 2024, down -7.28% year-over-year. Revenue in the quarter ending March 31, 2024 was $966.00K with 21.36% year-over-year growth. In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, a decrease of -17.77%.
Revenue (ttm)
$4.70M
Revenue Growth
-7.28%
P/S Ratio
20.95
Revenue / Employee
$71,197
Employees
66
Market Cap
86.41M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.53M | -979.00K | -17.77% |
Dec 31, 2022 | 5.51M | 1.03M | 23.11% |
Dec 31, 2021 | 4.47M | 3.65M | 443.62% |
Dec 31, 2020 | 823.00K | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 115.00K | -145.00K | -55.77% |
Dec 31, 2016 | 260.00K | -215.00K | -45.26% |
Dec 31, 2015 | 475.00K | 66.00K | 16.14% |
Dec 31, 2014 | 409.00K | 328.00K | 404.94% |
Dec 31, 2013 | 81.00K | -583.00K | -87.80% |
Dec 31, 2012 | 664.00K | 544.00K | 453.33% |
Dec 31, 2011 | 120.00K | -8.60M | -98.62% |
Dec 31, 2008 | 8.72M | -1.61M | -15.62% |
Dec 31, 2007 | 10.33M | 468.00K | 4.74% |
Dec 31, 2006 | 9.86M | 2.99M | 43.50% |
Dec 31, 2005 | 6.87M | -2.78M | -28.78% |
Dec 31, 2004 | 9.65M | -4.42M | -31.41% |
Dec 31, 2003 | 14.07M | -5.26M | -27.21% |
Dec 31, 2002 | 19.33M | 453.00K | 2.40% |
Dec 31, 2001 | 18.88M | 7.48M | 65.57% |
Dec 31, 2000 | 11.40M | 4.56M | 66.52% |
Dec 31, 1999 | 6.85M | -662.25K | -8.82% |
Dec 31, 1998 | 7.51M | 6.18M | 465.71% |
Dec 31, 1997 | 1.33M | -926.59K | -41.11% |
Dec 31, 1996 | 2.25M | 1.41M | 167.57% |
Dec 31, 1995 | 842.46K | - | - |
Dec 31, 1994 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PetMed Express | 276.97M |
Assertio Holdings | 142.05M |
FONAR | 102.72M |
Sensus Healthcare | 31.66M |
ProPhase Labs | 28.72M |
Clearside Biomedical | 8.45M |
Genelux | 8.00K |
ARMP News
- 12 days ago - Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva - PRNewsWire
- 3 months ago - Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit - PRNewsWire
- 6 months ago - Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update - PRNewsWire
- 7 months ago - Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference - PRNewsWire
- 7 months ago - Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023 - PRNewsWire
- 8 months ago - Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus - PRNewsWire